Loading clinical trials...
Loading clinical trials...
A Randomized Double-Blind Phase 2 Study Comparing the Efficacy, Safety, and Tolerability of Nitazoxanide Versus Placebo in Addition to Standard Care for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness
Conditions
Interventions
Nitazoxanide
Placebo
Locations
6
Mexico
Instituto Nacional de Pediatria
Coyoacán, Mexico
Hospital General Dr. Aurelio Valdivieso
Oaxaca City, Mexico
Hospital Central Dr. Ignacio Morones Prieto
San Luis Potosí City, Mexico
Hospital Infantil de Mexico Federico Gomez
Tamaulipas, Mexico
Instituto Nacional de Ciencias medicas y Nutricion Salvador Zubiran
Tlalpan, Mexico
Instituto Nacional de Enfermedades Respiratorias
Tlalpan, Mexico
Start Date
February 1, 2014
Primary Completion Date
May 1, 2017
Completion Date
January 1, 2018
Last Updated
August 1, 2018
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions